Healthcare-Associated Infection Mini-Summit 2020
Despite attention and improvements, healthcare-associated infections (HAIs) remain a challenge to healthcare professionals. According to the CDC, one in every 31 patients has at least one HAI each day. The Healthcare-Associated Infection Mini-Summit offers a 3.5-hour clinical program on several topics in the area of HAIs to provide current clinical knowledge and recommendations for infection prevention and treatment in order to improve clinical outcomes. Appropriate use of antimicrobials is addressed to promote antibiotic stewardship.
This educational activity is comprised of lecture presentations by subject matter experts. Presentation topics include:
- Healthcare-associated pneumonia—including both ventilator-associated and non-ventilator-associated pneumonia;
- Clostridium difficile infection and intra-abdominal infection;
- Surgical site infections—including prosthetic joint infection and cardiac device infection.
This event was supported by an unrestricted medical education grant from Merck to Sepsis Alliance. All event speakers are participating on a voluntary basis; participation does not indicate a relationship between the speakers and Merck or other Sepsis Alliance supporters.
This event was originally recorded on 12/10/2020.
Nurses, physicians, pharmacists, and other healthcare providers
At the end of the course, the attendee should be able to:
- Explain the oral microbiome's connection to nonventilator hospital-acquired pneumonia and sepsis.
- Describe clinical outcomes of patients with NVHAP in whom sepsis develops.
- Describe modifiable risk factors that address prevention of NVHAP and sepsis.
- Describe trends in the U.S. burden of Clostridioides difficile infection (CDI).
- Restate the major types of CDI diagnostic assays.
- Review recommended therapy for CDI.
- Identify potential strategies that have been proposed to prevent Ventilator-Associated Pneumonia.
- List potential sources of bias when evaluating Ventilator-Associated Pneumonia prevention studies.
- Delineate the prevention practices best associated with improving objective outcomes in mechanically ventilated patients.
- Describe the general approach to the management of intra-abdominal infection.
- Understand how to select empiric antimicrobial agents for the treatment of intra-abdominal infection.
- Recognize how principles of antimicrobial stewardship apply to anti-infective therapy of intra-abdominal infection.
- Identify risk factors for patients who develop cardiovascular implantable electronic device infections.
- Differentiate pocket infection from systemic infection.
- Identify laboratory and imaging modalities needed to definitively diagnose cardiovascular implantable electronic device infection.
- Identify treatment strategies for cardiovascular implantable electronic device infections.
- Describe the impact of prosthetic joint infection from the patients' perspectives.
- Implement strategies to medically optimize candidates for surgeries and to employ decolonization of bacteria.
- Utilize principles and practices of antibiotic stewardship for surgical prophylaxis.
Moderator & Presenter: Cindy Hou, DO, MA, MBA, FACOI, FACP, FIDSA
Infection Control Officer, Jefferson Health New Jersey
Dr. Cindy Hou is an infectious diseases specialist and serves as the Infection Control Officer for Jefferson Health New Jersey and Jefferson Medical Group. Locally, she is the physician lead for the hospital’s Antimicrobial Stewardship Committee, Infection Control Committee, Infection Prevention Task Force and Sepsis on the Floors Task Force. In 2018, she was the recipient of a national award as a Hero of Infection Prevention in Patient Safety from the Association of Professionals in Infection Control (APIC), and in 2019, she became the first infectious diseases physician to serve on the national Sepsis Alliance’s Advisory Board. Dr. Hou graduated from Yale University. She received her MA and MBA from Boston University, and D.O. from the University of New England College of Osteopathic Medicine. She is fellowed by the American College of Osteopathic Internists, the American College of Physicians, and the Infectious Diseases Society of America.
Dian Baker, PhD, RN
Professor, School of Nursing, California State University, Sacramento
Dr. Baker obtained her PhD from the University of Hawaii and completed a postdoctoral fellowship in healthcare leadership at the University of California, Davis. She was the academic partner and researcher with the Sutter Health System Team that was awarded the 2018 California Healthcare Quality Institute's C. Duane Dauner Quality Award for excellence in quality and safety for their work on non-ventilator hospital-acquired pneumonia. In 2020, Baker was part of the team awarded the Award for Publication Excellence from the Association for Professionals in Infection Control and Epidemiology and the American Journal of Infection Control. Baker and her colleagues formed the Hospital Acquired Pneumonia Prevention, Intervention, Research, and Education (HAPPIER) collaborative that includes nurse leaders, researchers, and partners in the UK. She is currently working to promote prevention of nonventilator hospital acquired pneumonia in hospitals worldwide and is a consultant for the VA National HAPPEN program. She is co-chair of a research workgroup for the National Organization to Prevent Hospital Acquired Pneumonia (NOHAP).
Michael Klompas MD, MPH
Hospital Epidemiologist, Brigham and Women’s Hospital; Professor of Population Medicine, Harvard Medical School
Dr. Michael Klompas is an Infectious Disease physician and the Hospital Epidemiologist at Brigham and Women’s Hospital in Boston as well as Professor of Population Medicine in Harvard Medical School. He has published widely on surveillance, diagnosis, prevention, and treatment of hospital-acquired pneumonia, ventilator-associated events, Covid-19, and sepsis. He was a member of the ATS-IDSA guideline panel on Management of Hospital-Acquired Pneumonia, is currently co-chair of the SHEA panel on Strategies to Prevent Ventilator-Associated Pneumonia, and serves on the Surviving Sepsis Campaign guideline panel.
Alice Guh, MD, MPH, FIDSA
Medical Officer, CDC, Division of Healthcare Quality Promotion
CDR Alice Guh, MD, MPH, is a U.S. Public Health Service Medical Officer in the Division of Healthcare Quality Promotion (DHQP) at the Centers for Disease Control and Prevention (CDC). She is board certified in Internal Medicine and Infectious Diseases. CDR Guh first joined CDC in 2007 as an Epidemic Intelligence Service Officer, where she was assigned to the Connecticut State Department of Public Health. She joined DHQP in 2009, where she provided technical expertise in investigations of healthcare-associated outbreaks and management of infection control breaches. In August 2014, CDR Guh assumed leadership of the Clostridioides difficile infection surveillance activity, which covers a population of 12 million persons, conducted through the CDC Emerging Infections Program. In this capacity, she leads special projects to advance C. difficile research and provides subject matter expertise on C. difficile epidemiology and surveillance.
John Mazuski, MD, PhD
Professor of Surgery, Washington University School of Medicine
John E. Mazuski, MD, PhD is a Professor of Surgery at Washington University in St. Louis, Missouri. He received his medical degree from the University of California, Los Angeles in 1981. He completed surgical residency in 1990, a fellowship in surgical critical care, and a PhD degree in biochemistry in 1993, all from the University of Minnesota. Dr. Mazuski is board certified in surgery and in surgical critical care by the American Board of Surgery. Dr. Mazuski’s clinical practice is centered on surgical critical care. He is the previous co-director of the Surgical Intensive Care Unit at Barnes-Jewish Hospital. His research interests focus on surgical infections, particularly intra-abdominal and soft tissue infections, and antimicrobial stewardship in surgical patients. Dr. Mazuski has been active in the development of evidence-based guidelines for the treatment of surgical and critically ill patients; these include several guidelines for the management of intra-abdominal infections, sepsis and septic shock, and prevention of surgical site infection. Dr. Mazuski is a past president of the Surgical Infection Society and has been recognized as a Master of Critical Care Medicine (MCCM) by the American College of Critical Care Medicine.
Uzma Syed, DO, FIDSA
Infectious Disease Specialist, Good Samaritan Hospital Medical Center
Dr. Uzma Syed is a board-certified Infectious Disease specialist, Chair of the COVID-19 Task Force, and is the Director of the Antimicrobial Stewardship Center of Excellence at Good Samaritan Hospital Medical Center. Dr. Syed is well-published in pneumonia-related research and has been leading several COVID-19 clinical trials. She teaches students of all ages as well as medical residents about her specialty. Dr. Syed is a member of the Inclusion, Diversity, Access & Equity Task Force of the Infectious Disease Society of America. Dr. Syed has been featured on several media outlets as an expert in Infectious Diseases.
Sepsis Alliance is approved by the California Board of Registered Nursing, Provider Number CEP17068 for 3.6 contact hours.
Other healthcare providers will receive a certificate of attendance for 3.0 contact hours.
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare provider. Sepsis Alliance recommends users consult their physician or healthcare provider regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.
- 3.00 Participation
- 3.00 RN CE Contact HoursProvider approved by the California Board of Registered Nursing, Provider Number CEP17068.